TE_1919
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | SVA_A |
|---|---|
| TE superfamily | SVA |
| TE class | Retroposon |
| Gene | PARK7, - |
| Class | Chimeric, Intergenic |
| Coding | Non-coding, Other |
| Tumor-specific score | 174.70 |
| Counts of samples | TCGA_tumor:154; TCGA_normal:0; GTEx:0 |
| TSS | chr1(+):7952846 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_1919.11 | PARK7 | Chimeric | Non-coding | Non-coding | chr1(+):7952847,7952891,7953713,7954315,7962763,7962875,7965324,7965425,7970894,7970963,7977652,7977738,7984894,7984914 |
| teRNA_1919.12 | PARK7 | Chimeric | Other | MGTGKSSSFFAEPAGCGHQNESGPSRCQGLDLPPCIRQAAHTPRKSARSLRQSDSRAQRPTRDALKEVTFRGCYSQTRPSSTRRIYVGSDPCKHRRDRASGWEHATVPPTAT* | chr1(+):7952847,7952891,7953713,7954315,7962763,7962875,7965324,7965425,7969345,7969404,7970894,7970914 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
